- Home
- MBNKP vs EXEL Comparison
MBNKP vs EXEL Comparison
Compare MBNKP & EXEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MBNKP
- EXEL
- Stock Information
- Founded
- MBNKP N/A
- EXEL 1994
- Country
- MBNKP United States
- EXEL United States
- Employees
- MBNKP 135
- EXEL N/A
- Industry
- MBNKP Commercial Banks
- EXEL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MBNKP Finance
- EXEL Health Care
- Exchange
- MBNKP Nasdaq
- EXEL Nasdaq
- Market Cap
- MBNKP N/A
- EXEL 9.8B
- IPO Year
- MBNKP 2019
- EXEL 2000
- Fundamental
- Price
- MBNKP $25.43
- EXEL $38.47
- Analyst Decision
- MBNKP
- EXEL Buy
- Analyst Count
- MBNKP 0
- EXEL 18
- Target Price
- MBNKP N/A
- EXEL $37.59
- AVG Volume (30 Days)
- MBNKP N/A
- EXEL 2.4M
- Earning Date
- MBNKP N/A
- EXEL 05-02-2025
- Dividend Yield
- MBNKP N/A
- EXEL N/A
- EPS Growth
- MBNKP N/A
- EXEL 170.77
- EPS
- MBNKP N/A
- EXEL 1.76
- Revenue
- MBNKP N/A
- EXEL $2,168,701,000.00
- Revenue This Year
- MBNKP N/A
- EXEL $5.82
- Revenue Next Year
- MBNKP N/A
- EXEL $10.81
- P/E Ratio
- MBNKP N/A
- EXEL $21.27
- Revenue Growth
- MBNKP N/A
- EXEL 18.50
- 52 Week Low
- MBNKP N/A
- EXEL $20.14
- 52 Week High
- MBNKP N/A
- EXEL $40.02
- Technical
- Relative Strength Index (RSI)
- MBNKP 61.53
- EXEL 57.87
- Support Level
- MBNKP $25.18
- EXEL $35.34
- Resistance Level
- MBNKP $25.64
- EXEL $37.67
- Average True Range (ATR)
- MBNKP 0.23
- EXEL 1.32
- MACD
- MBNKP 0.05
- EXEL 0.22
- Stochastic Oscillator
- MBNKP 88.68
- EXEL 95.46
About MBNKP Medallion Bank Fixed-to-Floating Rate Non-Cumulative Perpetual Preferred Stock Series F
Medallion Bank is engaged in providing consumer loans, raising deposits, and managing other banking activities. It offers affordable financing for home improvement contractors, including window, siding, and roof replacements; kitchen, bath, and basement remodels; HVAC (Heating Ventilation and Air Conditioning), and solar PV installations. Medallion also offers recreation financing for new and used motorhomes, towable RVs, truck campers, cargo trailers, utility trailers, horse trailers, and a variety of ATVs and other power sport vehicles. Its segments are Recreation, Home Improvement, and Other. The company generates maximum revenue from the Recreation segment.
About EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.